<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection:</title>
    <link>http://13.232.72.61:8080/jspui/handle/123456789/6486</link>
    <description />
    <pubDate>Sat, 04 Apr 2026 04:21:59 GMT</pubDate>
    <dc:date>2026-04-04T04:21:59Z</dc:date>
    <item>
      <title>Nanopaticulate Drug Delivery System for Anti-Cancer Drugs</title>
      <link>http://13.232.72.61:8080/jspui/handle/123456789/6510</link>
      <description>Title: Nanopaticulate Drug Delivery System for Anti-Cancer Drugs
Authors: Tajmal, Mandana; Goli, Divakar
Abstract: An attempt was made in this study to formulate and evaluate the polymeric&#xD;
nanoparticles of anti-cancer drug using biodegradable and biocompatible polymers&#xD;
such as chitosan and PLGA. In this formulation Gefitinib was used as model drug&#xD;
because of its wide range of use in treatment of cancer such as non-small cell lung&#xD;
cancer, breast cancer, pancreatic cancer etc., in the form of tablet. FTIR and DSC&#xD;
confirmed that there is no interaction between the drug and polymers and excipients&#xD;
used in the formulations. Gefitinib loaded chitosan nanoparticles were prepared using&#xD;
ionic gelation technique and use of different concentrations of chitosan and STPP was&#xD;
used as cross linker. Gefitinib loaded PLGA nanoparticles were prepared by means of&#xD;
nanoprecipitation method and emulsification followed by homogenization technique&#xD;
using different concentrations of PLGA and stabilized by PVA. The prepared&#xD;
nanoparticles were characterized in case of %entrapment efficiency, particle size, poly&#xD;
dispersity index, zeta potential, %release upto 72 h. After response optimization&#xD;
study, GCN1 and A5 were selected as optimized formulations. Morphological&#xD;
characterization by SEM, stability studies, in-vitro cytotoxicity studies on A549 cell&#xD;
lines by MTT assay and in-vivo anti-cancer effect on non-small cell lung cancer&#xD;
induced nude mice were done for optimized formulations. Effect of the prepared&#xD;
nanoparticles were evaluated for body weight change, blood hematological&#xD;
parameters, mean survival time and %increase in life span and compared with&#xD;
Gefitinib. A5 and GCN1 showed 29.16% and 20.83% increase in life span as&#xD;
compared with Gefitinib which showed 16.66%. Thus the study revealed that the&#xD;
developed nanopaticulate system has a great appeal for the conventional treatment for&#xD;
non-small cell lung cancer.
Description: Theses</description>
      <pubDate>Thu, 01 Oct 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://13.232.72.61:8080/jspui/handle/123456789/6510</guid>
      <dc:date>2020-10-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Design and evaluation of drug loaded polymeric nanoparticles of antibacterial agent for the treatment of pneumonia</title>
      <link>http://13.232.72.61:8080/jspui/handle/123456789/6509</link>
      <description>Title: Design and evaluation of drug loaded polymeric nanoparticles of antibacterial agent for the treatment of pneumonia
Authors: H M, Ashvini; Kalyanap, Shivanand
Abstract: Aim: The current research was aimed at formulating and optimizing polymeric&#xD;
nanoparticles of clarithromycin (an antibacterial agent) in terms of particle size,&#xD;
entrapment efficiency, in vitro release behaviors and antibacterial efficiency against&#xD;
S. Pneumoniea.&#xD;
Methods: Clarithromycin loaded polymeric nanoparticles are prepared using chitosan&#xD;
(low molecular weight) by ionic gelation method and Poly (lactide –co-glycolic acid)&#xD;
(50:50 monomer ratio) by emulsification solvent evaporation and nanoprecepitation&#xD;
method. Tripolyphosphate used as a cross linker and polyvinyl alcohol, poloxamer-&#xD;
188 as stabilizers. Carbapol, Poloxmer-188 and Tween 80 were added as co-stabilizer&#xD;
and co-surfactant respectively. Clarithromycin –β-cyclodextrin complex was prepared&#xD;
and incorporated into chitosan nanoparticles. Minitab 17 statistical software was&#xD;
employed to create general full factorial design. NPs were characterized in terms of&#xD;
surface morphology, particle size and distribution, zeta potential, encapsulation&#xD;
efficiency, clarithromycin release profile and antibacterial activity. The antibacterial&#xD;
activity of nanoparticles against S. Pneumoniea was evaluated by calculation of&#xD;
minimum inhibitory concentration and zone of inhibition. Drug-excipient&#xD;
compatibility study by FTIR and DSC revealed no possible interactions.
Description: Theses</description>
      <pubDate>Tue, 01 May 2018 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://13.232.72.61:8080/jspui/handle/123456789/6509</guid>
      <dc:date>2018-05-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Nanoparticulate mediated targeted drug delivery system of anti-Alzheimer’s drug;Nanoparticulate mediated targeted drug delivery system of anti-Alzheimer’s drug;</title>
      <link>http://13.232.72.61:8080/jspui/handle/123456789/6508</link>
      <description>Title: Nanoparticulate mediated targeted drug delivery system of anti-Alzheimer’s drug;Nanoparticulate mediated targeted drug delivery system of anti-Alzheimer’s drug;
Authors: Patel, Kinjal Chetankumar; Goli, Divakar
Abstract: In present study, we aimed to formulate RT loaded nanoparticles, which will give the&#xD;
best result for improvement of memory, cognitive deficits and prevention against&#xD;
degeneration of hippocampus in Alzheimer’s disease. We prepared two types of&#xD;
nanoparticles: Polymeric and Solid lipid nanoparticles. Polymeric nanoparticles&#xD;
PLGA-CS-Tween 80, PLGA-CS-PEGs and PLGA-Soya lecithin-Tween 80 were&#xD;
prepared by emulsification-solvent evaporation, oil-in-water (O/W) single emulsion&#xD;
solvent evaporation method, modified nanoprecipitation technique combined with self&#xD;
assembly respectively. Solid lipid nanoparticles were prepared by modified cold&#xD;
homogenization method. The nanoparticles were evaluated for FTIR, DSC, particle&#xD;
size, polydispersity, zetapotential, in vitro drug release, stability study, SEM,&#xD;
behavioral study and histopathology of hippocampus. The FTIR and DSC study&#xD;
demonstrated that there was no interaction between drug, polymers and lipids, which&#xD;
indicated that they are compatible with each other. Using factorial design for&#xD;
optimization we tried to achieve higher entrapment efficiency and drug release with&#xD;
smaller particle size (&lt;200 nm) and narrow polydispersity index, with less number of&#xD;
experiments. The SEM study showed that particles were spherical in shape with&#xD;
smooth/rough surface. The stability study for six months demonstrated that the&#xD;
formulations were stable at refrigerator (3-5 °C) condition, hence is the most suitable&#xD;
condition for the storage of nanoparticles. Administration of optimized formulations&#xD;
of polymeric and solid lipid nanoparticles in Aluminium chloride induced&#xD;
Alzheimer’s disease model (Wistar rats) results in noticeable improvement in learning&#xD;
and memory capacity and it antagonized the toxic effect of Aluminium chloride by&#xD;
reduction in escape latency compared to standard drug solution treated animals.
Description: Theses</description>
      <pubDate>Tue, 01 Mar 2016 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://13.232.72.61:8080/jspui/handle/123456789/6508</guid>
      <dc:date>2016-03-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Bioparametric investigation on the production of alkaline protease by a newly isolated thermoactinomyces thalpophilus PE-120</title>
      <link>http://13.232.72.61:8080/jspui/handle/123456789/6507</link>
      <description>Title: Bioparametric investigation on the production of alkaline protease by a newly isolated thermoactinomyces thalpophilus PE-120
Authors: Goli, Divakar; P, Ellaiah
Abstract: Bioparametric investigation on the production of alkaline protease by a newly isolated thermoactinomyces thalpophilus PE-120
Description: Theses</description>
      <pubDate>Wed, 01 Jan 2003 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://13.232.72.61:8080/jspui/handle/123456789/6507</guid>
      <dc:date>2003-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

